Emerging role for interferons in respiratory viral infections and childhood asthma
Author
Bosco, A.Affiliation
Asthma and Airway Disease Research Center, University of ArizonaDepartment of Immunobiology, The University of Arizona College of Medicine
Issue Date
2023-02-20Keywords
childhood asthmainnate immunity
interferons
respiratory syncytial virus
rhinovirus
systems biology
trained immunity
Metadata
Show full item recordPublisher
Frontiers Media S.A.Citation
Bosco A (2023) Emerging role for interferons in respiratory viral infections and childhood asthma. Front. Immunol. 14:1109001. doi: 10.3389/fimmu.2023.1109001Journal
Frontiers in ImmunologyRights
© 2023 Bosco. This is an open-access article distributed under the terms of the Creative Commons Attribution License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Respiratory syncytial virus (RSV) and Rhinovirus (RV) infections are major triggers of severe lower respiratory illnesses (sLRI) in infants and children and are strongly associated with the subsequent development of asthma. Decades of research has focused on the role of type I interferons in antiviral immunity and ensuing airway diseases, however, recent findings have highlighted several novel aspects of the interferon response that merit further investigation. In this perspective, we discuss emerging roles of type I interferons in the pathogenesis of sLRI in children. We propose that variations in interferon response patterns exist as discrete endotypes, which operate locally in the airways and systemically through a lung-blood-bone marrow axis. We discuss new insights into the role of interferons in immune training, bacterial lysate immunotherapy, and allergen-specific immunotherapy. Interferons play complex and diverse roles in the pathogenesis of sLRI and later asthma, providing new directions for mechanistic studies and drug development. Copyright © 2023 Bosco.Note
Open access journalISSN
1664-3224PubMed ID
36895568Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.3389/fimmu.2023.1109001
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2023 Bosco. This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Related articles
- Comparing respiratory syncytial virus and rhinovirus in development of post-viral airway disease.
- Authors: Narayanan D, Grayson MH
- Issue date: 2022 Mar
- Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions.
- Authors: Binns E, Tuckerman J, Licciardi PV, Wurzel D
- Issue date: 2022 Oct
- Interferon response to respiratory syncytial virus by bronchial epithelium from children with asthma is inversely correlated with pulmonary function.
- Authors: Altman MC, Reeves SR, Parker AR, Whalen E, Misura KM, Barrow KA, James RG, Hallstrand TS, Ziegler SF, Debley JS
- Issue date: 2018 Aug
- Role of viral infections in the development and exacerbation of asthma in children.
- Authors: Jartti T, Gern JE
- Issue date: 2017 Oct
- Immunoglobulin E-virus phenotypes of infant bronchiolitis and risk of childhood asthma.
- Authors: Shibata R, Zhu Z, Ooka T, Freishtat RJ, Mansbach JM, Pérez-Losada M, Ramos-Tapia I, Teach S, Camargo CA Jr, Hasegawa K
- Issue date: 2023